13F-HR filed by Boxer Capital Management, LLC
Boxer Capital Management, LLC filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-15, with 54 holding rows worth $761,653,648.
- Accession
- 0001213900-26-057335
- Filer
- CIK 2018299
- Filed
- 2026-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 54 entries on the cover page, a total value of $761,653,648 stated on the cover page (in dollars after the unit check, H1), rows summing to $761,653,648 with VALUE read as dollars as filed, 13F file number 028-25329. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TANGO THERAPEUTICS INC | 87583X109 | COM | 10,876,219 | $227,530,501 | dollars as filed | |
| KODIAK SCIENCES INC | 50015M109 | COM | 1,361,000 | $51,881,320 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 500,000 | $48,625,000 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 329,100 | $27,410,739 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 225,000 | $25,681,500 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 766,318 | $22,322,843 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 200,000 | $22,270,000 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 375,000 | $19,770,000 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 325,000 | $18,885,750 | dollars as filed | |
| CAPRICOR THERAPEUTICS INC | 14070B309 | COMMON STOCK | 590,000 | $17,936,000 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 170,000 | $17,918,000 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 1,866,000 | $16,719,360 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 1,100,000 | $16,093,000 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 46,457 | $14,967,981 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 200,000 | $13,626,000 | dollars as filed | |
| PRECIGEN INC | 74017N105 | COM | 3,500,000 | $13,545,000 | dollars as filed | |
| DEFINIUM THERAPEUTICS INC | 24477V105 | COM SHS | 598,500 | $11,311,650 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 800,000 | $11,120,000 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 662,000 | $10,823,700 | dollars as filed | |
| OPUS GENETICS INC | 67577R102 | COMMON STOCK | 2,250,000 | $10,237,500 | dollars as filed | |
| CORCEPT THERAPEUTICS INC | 218352102 | COM | 250,000 | $10,077,500 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 500,000 | $8,990,000 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 1,175,000 | $8,988,750 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 225,000 | $8,660,250 | dollars as filed | |
| PALISADE BIO INC | 696389402 | COMMON STOCK | 4,799,875 | $8,399,781 | dollars as filed | |
| CRESCENT BIOPHARMA INC. | 38000Q201 | COM | 453,686 | $8,334,212 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 200,000 | $6,696,000 | dollars as filed | |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 2,725,000 | $6,649,000 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 100,000 | $6,591,000 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 494,000 | $6,451,640 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 70,000 | $5,891,900 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 842,106 | $5,861,058 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 900,000 | $5,355,000 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 275,000 | $5,126,000 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 300,000 | $4,479,000 | dollars as filed | |
| INOVIO PHARMACEUTICALS I | 45773H409 | COMMON STOCK | 2,370,122 | $4,124,012 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 75,000 | $3,615,000 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 150,000 | $3,264,000 | dollars as filed | |
| CYBIN INC | 23256X407 | COM NEW | 640,000 | $3,072,000 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 350,000 | $2,964,500 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 749,035 | $2,561,700 | dollars as filed | |
| CLENE INC | 185634201 | COM NEW | 477,515 | $2,354,149 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 176,500 | $2,236,255 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 300,000 | $2,160,000 | dollars as filed | |
| INVIVYD INC | 00534A102 | COMMON STOCK | 1,500,000 | $1,950,000 | dollars as filed | |
| LB PHARMACEUTICALS INC | 50180M108 | COMMON STOCK | 70,000 | $1,726,200 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U205 | COMMON STOCK | 302,536 | $1,685,126 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 100,000 | $1,550,000 | dollars as filed | |
| UPSTREAM BIO INC | 91678A107 | COMMON STOCK | 150,000 | $1,350,000 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 666,666 | $793,333 | dollars as filed | |
| PEPGEN INC COM | 713317105 | Stock | 272,892 | $483,019 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 20,400 | $410,652 | dollars as filed | |
| REGENXBIO INC | 75901B107 | COM | 15,000 | $125,700 | dollars as filed | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 66,666 | $1,067 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001213900-26-057335 | this filing | 2026-05-15 | acceptance time not in the bulk data set |